DocuSign Files Q2 2024 10-Q Report

TL;DR

DocuSign's Q2 10-Q is in: financials for period ending 7/31/24 are here.

AI Summary

DocuSign, Inc. filed its 10-Q for the period ending July 31, 2024, reporting financial results. The company's fiscal year ends January 31, and this filing covers the second quarter. Key financial data and business operations for this period are detailed within the report.

Why It Matters

This filing provides investors and analysts with the latest financial performance and operational updates for DocuSign, crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: medium — 10-Q filings are standard financial reports, but the specific details within can reveal significant risks or opportunities.

Key Numbers

• 2024-07-31 — Reporting Period End Date (This is the end date for the financial data presented in the 10-Q.)
• 2024-09-06 — Filing Date (This is the date the 10-Q was officially submitted to the SEC.)
• 0131 — Fiscal Year End (Indicates the end of DocuSign's fiscal year.)

Key Players & Entities

• DOCUSIGN, INC. (company) — Filer of the 10-Q report
• 20240731 (date) — End of the reporting period
• 20240906 (date) — Filing date of the report
• 221 MAIN ST., SUITE 1550 (address) — Company's business and mail address
• SAN FRANCISCO, CA 94105 (address) — Company's business and mail city, state, and zip

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share DOCU The Nasdaq Global Select
• $0 — 2,713 shares of common stock, par value $0.0001, outstanding at August 30, 2024.

Filing Documents

• docu-20240731.htm (10-Q) — 1637KB
• q225exhibit311.htm (EX-31.1) — 10KB
• q225exhibit312.htm (EX-31.2) — 10KB
• q225exhibit321.htm (EX-32.1) — 8KB
• 0001261333-24-000121.txt ( ) — 7267KB
• docu-20240731.xsd (EX-101.SCH) — 42KB
• docu-20240731_cal.xml (EX-101.CAL) — 81KB
• docu-20240731_def.xml (EX-101.DEF) — 235KB
• docu-20240731_lab.xml (EX-101.LAB) — 659KB
• docu-20240731_pre.xml (EX-101.PRE) — 436KB
• docu-20240731_htm.xml (XML) — 859KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited) Condensed Consolidated Balance Sheets as of July 31, 2024 and January 31, 2024 4 Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Six Months Ended July 31, 2024 and 2023 5 Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended July 31, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the Six Months Ended July 31, 2024 and 2023 8 Notes to Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 39 Item 4.

Controls and Procedures

Controls and Procedures 39

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 41 Item 1A.

Risk Factors

Risk Factors 42 Item 2 . Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 68 Item 5. Other Information 69 Item 6. Exhibits 69 Exhibit Index 70

Signatures

Signatures 71 Docusign, Inc. | 2025 Form 10-Q | 2 NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risk and uncertainties. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future operating results and financial position, our business strategy and plans, market growth and trends, our anticipated future products and product strategy, our objectives for future operations, and the impact of such assumptions on our financial condition and results of operations are forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about: our expectations regarding global macro-economic conditions, including the effects of inflation, volatile interest rates, and market volatility on the global economy; our ability to estimate the size and growth of our total addressable market; our ability to compete effectively in an evolving and competitive market; the impact of any data breaches, cyberattacks or other malicious activity on our technology systems; our ability to effectively sustain and manage our growth and future expenses and maintain or increa

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS DOCUSIGN, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands, except per share data) July 31, 2024 January 31, 2024 Assets Current assets Cash and cash equivalents $ 619,064 $ 797,060 Investments—current 319,289 248,402 Accounts receivable, net of allowance for doubtful accounts of $ 7,816 and $ 5,499 as of July 31, 2024 and January 31, 2024 309,885 439,299 Contract assets—current 13,449 15,922 Prepaid expenses and other current assets 81,693 66,984 Total current assets 1,343,380 1,567,667 Investments—noncurrent 102,537 121,977 Property and equipment, net 265,544 245,173 Operating lease right-of-use assets 117,877 123,188 Goodwill 455,519 353,138 Intangible assets, net 90,227 50,905 Deferred contract acquisition costs—noncurrent 427,599 409,627 Deferred tax assets—noncurrent 822,026 2,031 Other assets—noncurrent 129,232 97,584 Total assets $ 3,753,941 $ 2,971,290 Liabilities and Equity Current liabilities Accounts payable $ 8,116 $ 19,029 Accrued expenses and other current liabilities 93,251 104,037 Accrued compensation 178,603 195,266 Contract liabilities—current 1,307,565 1,320,059 Operating lease liabilities—current 19,769 22,230 Total current liabilities 1,607,304 1,660,621 Contract liabilities—noncurrent 23,020 21,980 Operating lease liabilities—noncurrent 115,832 120,823 Deferred tax liability—noncurrent 18,122 16,795 Other liabilities—noncurrent 28,257 21,332 Total liabilities 1,792,535 1,841,551 Commitments and contingencies ( Note 9 ) Stockholders' equity Preferred stock, $ 0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of July 31, 2024 and January 31, 2024 — — Common stock, $ 0.0001 par value; 500,000 shares authorized, 202,296 shares outstanding as of July 31, 2024; 500,000 shares authorized, 205,326 shares outstanding as of January 31, 2024 20 21 Treasury stock, at cost: 26 shares as of July 31, 2024; 18 share

View Full Filing

View this 10-Q filing on SEC EDGAR